AiPrise | $12,500,000 | (Oct 10, 2025)
Glue(US) | $20,000,000 | (Oct 10, 2025)
Certified by Founder
Lodge
Arthrosi Therapeutics, Inc.
start up
United States
- San Diego, California
- 10/10/2025
- Series E
- $153,000,000
Arthrosi Therapeutics is a leading clinical-stage biotech company dedicated to advancing therapies for gout disease. Our proprietary oral drug candidate, AR882 which is currently in clinical Phase 3, has demonstrated unprecedented sustained urate lowering in gout patients and reduction of tophi, showing exceptional potential to treat millions of patients suffering from gout and tophaceous gout. At Arthrosi Therapeutics, we are committed to transforming the treatment landscape and improving the lives of patients worldwide.
- Industry Pharmaceutical Manufacturing
- Website https://arthrosi.com/
- LinkedIn https://www.linkedin.com/company/arthrosi-therapeutics-inc/
Nilo Therapeutics | $101,000,000 | (Oct 10, 2025)
Mentium.io | $3,200,000 | (Oct 10, 2025)
Vulcan Technologies | $10,900,000 | (Oct 10, 2025)
Knapsack | $10,000,000 | (Oct 10, 2025)
Search Party | $3,500,000 | (Oct 10, 2025)
enurgen | $4,100,000 | (Oct 10, 2025)
Echelon AI | $4,750,000 | (Oct 10, 2025)
Asterix Foods | $4,200,000 | (Oct 10, 2025)
FurtherAI | $25,000,000 | (Oct 10, 2025)